Thyroid Cancer
Showing 1 - 25 of 273
Thyroid Cancer Trial in Medellin (Traditional neck dissection approach, Anterior neck dissection approach)
Recruiting
- Thyroid Cancer
- Traditional neck dissection approach
- Anterior neck dissection approach
-
Medellin, Antioquia, ColombiaHospital Alma Mater de Antioquia
Nov 20, 2023
Thyroid Cancer Trial (20 mg Famitinib & 1200 mg Adebrelimab)
Not yet recruiting
- Thyroid Cancer
- 20 mg Famitinib & 1200 mg Adebrelimab
- (no location specified)
Nov 26, 2023
Thyroid Cancer, Lymph Node Trial in Leon (US-guided fine needle aspiration (FNA))
Completed
- Thyroid Cancer
- Lymph Node
- US-guided fine needle aspiration (FNA)
-
Leon, Guanajuato, MexicoUnidad Medica de Alta Especialidad No. 1, Bajío
Nov 6, 2023
Thyroid Cancer Trial (Pectoral nerve block)
Not yet recruiting
- Thyroid Cancer
- Pectoral nerve block
- (no location specified)
Oct 25, 2023
Thyroid Cancer, Surgery, Recurrence Trial in Beijing (Thyroxine)
Recruiting
- Thyroid Cancer
- +2 more
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 13, 2023
Thyroid Cancer, Recurrence Trial in Beijing (prophylactic central neck dissection)
Recruiting
- Thyroid Cancer
- Recurrence
- prophylactic central neck dissection
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Science
Oct 8, 2023
Thyroid Cancer Trial in Ann Arbor (Usual Care, CQUPLE)
Recruiting
- Thyroid Cancer
- Usual Care
- CQUPLE
-
Ann Arbor, MichiganThe University of Michigan Cancer Center
Oct 3, 2023
Thyroid Cancer Trial in Seoul (Three-dimensional patient-specific bioprinting trachea implantation)
Active, not recruiting
- Thyroid Cancer
- Three-dimensional patient-specific bioprinting trachea implantation
-
Seoul, Korea, Republic ofSeoul St. Mary's Hospital
Sep 20, 2023
Advanced Solid Tumor, Lung Cancer, Pancreas Cancer Trial in Chengdu (CNSI-Fe(II) 30 mg, CNSI-Fe(II) 60 mg, CNSI-Fe(II) 90 mg)
Recruiting
- Advanced Solid Tumor
- +8 more
- CNSI-Fe(II) 30 mg
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Sep 15, 2023
Quality of Life in Differentiated Thyroid Carcinoma Undergoing
Not yet recruiting
- Thyroid Cancer
- minimally invasive procedure
-
Guangzhou, Guangdong, ChinaSun Yat-sen Memorial Hopsital
Sep 13, 2023
Nasolacrimal Duct Obstruction, Thyroid Cancer Trial (Artificial Tears Methylcellulose)
Not yet recruiting
- Nasolacrimal Duct Obstruction
- Thyroid Cancer
- Artificial Tears Methylcellulose
- (no location specified)
Aug 17, 2023
Cross-sectional Case and Control Study on Quality of Life,
Recruiting
- Papillary Thyroid Carcinoma
- Thyroid Cancer
- Thyroid lobectomy via trans-axillary approach
- Thyroid lobectomy via open approach
-
Beijing, Beijing, ChinaDepartment of General Surgery, Peking Union Medical College Hosp
Jul 5, 2023
Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),
Recruiting
- Solid Tumor, Adult
- +19 more
- SNS-101 (anti-VISTA)
- Cemiplimab
-
Irving, Texas
- +2 more
May 24, 2023
Thyroidectomy, Goiter, Thyroid Cancer Trial in Taipei (Oxidized regenerated cellulose(ORC), Hyaluronic acid(HA))
Recruiting
- Thyroidectomy
- +2 more
- Oxidized regenerated cellulose(ORC)
- Hyaluronic acid(HA)
-
Taipei, TaiwanNational Taiwan University Hospital
May 1, 2023
Disease Burden, Genetic Heterogeneity and Tumour Evolution in
Recruiting
- Thyroid Cancer
- Sample collection only
-
London, United KingdomThe Royal Marsden NHS Foundation Trust
Apr 28, 2023
HRQOL in Locally Advanced Thyroid Carcinoma
Recruiting
- Thyroid Cancer
- +2 more
- Tyrosine kinase inhibitor drugs.
-
Fuzhou, Fujian, ChinaRoad Fuma No.420
Apr 11, 2023
Surgical Management of Advanced Thyroid Cancer
Recruiting
- Thyroid Carcinoma
- +6 more
- Thyroidectomy with or without lymphadenectomy or multivisceral resection
-
Rome, ItalyFondazione Policlinico Universitario Agostino Gemelli IRCCS
Mar 31, 2023
Optimize Detection of NTRK1,2,3 Fusions in Thyroid Cancer
Recruiting
- Thyroid Cancer
- NTRK fusion assessment
-
Roma, ItalyRegina Elena National Cancer Institute
Mar 31, 2023
NSCLC, Non-small Cell Carcinoma, Histiocytic Tumor Trial (BDTX-4933)
Not yet recruiting
- Non-small Cell Lung Cancer
- +32 more
- (no location specified)
Mar 30, 2023
Carotid Intima-media Thickness in Patients Undergoing Thyroid
Recruiting
- Plummer Disease
- +6 more
- Experimental
-
Milan, ItalyIstituto Auxologico Italiano , IRCCS
Mar 7, 2023
Thyroid Cancer Trial in Hangzhou (Resection based on "thymus-vascular-inferior parathyroid" complex)
Not yet recruiting
- Thyroid Cancer
- Resection based on "thymus-vascular-inferior parathyroid" complex
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital Zhejiang University School of Medicin
Feb 24, 2023
Role of Endocrine Disruptors in Thyroid Cancer
Recruiting
- Endocrine Disruptor Chemicals
- Thyroid Cancer
- Blood and urine diagnostic evaluation
-
Milan, ItalyIstituto Auxologico Italiano, IRCCS
Feb 28, 2023
s and Clinical Variables on Thyroid Cancer
Recruiting
- Thyroid Cancer
-
Milan, ItalyIstituto Auxologico Italiano, IRCCS
Mar 1, 2023